PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 25168935-6 2015 GLUT1 antibody conjugation can effectively target the injected Fe3O4 NPs to GLUT1-positive tumor cells in infantile hemangioma. ferryl iron 63-68 solute carrier family 2 member 1 Homo sapiens 0-5 25168935-0 2015 MRI molecular imaging using GLUT1 antibody-Fe3O4 nanoparticles in the hemangioma animal model for differentiating infantile hemangioma from vascular malformation. ferryl iron 43-48 solute carrier family 2 member 1 Homo sapiens 28-33 25168935-1 2015 The purpose of this study is to evaluate the efficacy of glucose transporter protein 1 (GLUT1) antibody-conjugated iron oxide nanoparticles (Fe3O4 NPs) as magnetic resonance imaging (MRI) molecular imaging agents for differentiating infantile hemangioma from vascular malformation in the hemangioma animal model. ferryl iron 141-146 solute carrier family 2 member 1 Homo sapiens 57-86 25168935-1 2015 The purpose of this study is to evaluate the efficacy of glucose transporter protein 1 (GLUT1) antibody-conjugated iron oxide nanoparticles (Fe3O4 NPs) as magnetic resonance imaging (MRI) molecular imaging agents for differentiating infantile hemangioma from vascular malformation in the hemangioma animal model. ferryl iron 141-146 solute carrier family 2 member 1 Homo sapiens 88-93 25168935-2 2015 The conjugation of Fe3O4 NPs with anti-GLUT1 antibodies leads to a significantly increased uptake of NPs by human umbilical vein endothelial cells. ferryl iron 19-24 solute carrier family 2 member 1 Homo sapiens 39-44 25168935-3 2015 MRI imaging following the intravenous injection of GLUT1 antibody-Fe3O4 NPs yielded a significantly lower signal intensity than did unconjugated Fe3O4 NPs. ferryl iron 66-71 solute carrier family 2 member 1 Homo sapiens 51-56 25168935-4 2015 Upon histological examination of the GLUT1 antibody-Fe3O4 NPs, Prussian blue-stained NPs were identified in CD31-positive endothelial cells of hemangioma. ferryl iron 52-57 solute carrier family 2 member 1 Homo sapiens 37-42 25168935-6 2015 GLUT1 antibody conjugation can effectively target the injected Fe3O4 NPs to GLUT1-positive tumor cells in infantile hemangioma. ferryl iron 63-68 solute carrier family 2 member 1 Homo sapiens 76-81 24184535-2 2014 SiO2@indol-IL can inhibit the proliferation of HepG-2 cells in 48 h. Fe3O4@indol-IL can mimic the function of catalase to disproportionate H2O2 to O2, and has obvious effect on the proliferation of HepG-2 cells in 72 h. Moreover, the two nanoparticles show some inhibition on the expression of hypoxia inducible factor (HIF-1alpha), glucose transporter (GLUT1) and the production of lactate in HepG-2 cells. ferryl iron 69-74 solute carrier family 2 member 1 Homo sapiens 354-359